Evidence map›Paper›PMID 39712746›Full record

ArticleCureus2024

Cost Comparisons of Physician-Ordered Versus Direct-to-Consumer Laboratory Testing.

Trevor Lin, Curtis E Margo

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Trevor LinDepartment of Ophthalmology, Morsani College of Medicine, University of South Florida, Tampa, USA.
Curtis E MargoDepartment of Ophthalmology, Morsani College of Medicine, University of South Florida, Tampa, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives To determine if direct-to-consumer (DTC) laboratory testing is less expensive for patients, as is generally advertised, and whether it has any role in managing uninsured or underinsured patients. Methods The costs of six commonly ordered laboratory tests were obtained through two major DTC laboratories and compared with 42 physician-ordered, hospital-based laboratories in Florida. The costs of DTC tests were also compared to concurrent reimbursements from Medicare and Medicaid. Results The costs of DTC tests were generally lower than the mean insurance-negotiated hospital-based prices and much less costly than physician-ordered tests for patients without insurance. Charges were greater than reimbursements from Medicaid and Medicare. The inter-hospital variation in the pricing of laboratory tests was remarkably wide for both insured and uninsured patients. Conclusions Charges to insured patients for physician-ordered laboratory tests tend to be higher than those offered directly to consumers, but out-of-pocket costs will vary depending on deductibles and co-pays. DTC costs would be substantially less for uninsured patients when ordered by a patient under the supervision of a physician.

Indexed as

laboratory chargeslaboratory costslaboratory testspatient educationuninsured patients

Identifiers

PMID39712746
PMCPMC11663041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.